BACKGROUND: Fetal exposure to maternal glucocorticoids may determine fetal growth and the programing of later disorders. Availability of the glucocorticoids in the placenta is regulated by the 11beta-hydroxysteroid dehydrogenase (11beta-HSDs) enzymes. To date, there are discrepancies with regard to cortisol (F) cord blood levels in fetuses with intrauterine growth retardation in different species. Objective To study the expression and activity of 11beta-HSDs in placentas from full term small for gestational age (SGA), appropriate for gestational age (AGA) and large for gestational age (LGA) newborns, and cortisol cord blood concentration. METHODS: Twenty-five placentas from AGA, 24 SGA and 25 LGA were collected. RESULTS: SGA newborns had significantly lower and LGA newborns had significantly higher birth weight, birth length, head circumference, and placental weight than AGA counterparts. We observed a direct correlation between placental weight and birth weight, birth length and head circumference, and higher cord F levels in SGA newborns. The 11beta-HSD1 expression was similar among the SGA, AGA, and LGA placentas. However, within the placentas of SGA newborns, the 11beta-HSD1 mRNA levels were significantly reduced in the chorionic plate compared with basal plate. An inverse correlation between cord F levels and activity of 11beta-HSD1 in the chorionic plate of the SGA placentas was detected. The 11beta-HSD2 activity was seven- to eightfold higher compared with 11beta-HSD1 in the placentas, and there was a lower 11beta-HSD2 activity in females' SGA placentas compared with the male SGA placentas. CONCLUSION: We observed a lower expression and activity of 11beta-HSD1 in the chorionic plate of the SGA placentas, suggesting a possible compensatory mechanism to diminish the higher cortisol fetal concentrations observed in fetuses with intrauterine growth restriction.
BACKGROUND: Fetal exposure to maternal glucocorticoids may determine fetal growth and the programing of later disorders. Availability of the glucocorticoids in the placenta is regulated by the 11beta-hydroxysteroid dehydrogenase (11beta-HSDs) enzymes. To date, there are discrepancies with regard to cortisol (F) cord blood levels in fetuses with intrauterine growth retardation in different species. Objective To study the expression and activity of 11beta-HSDs in placentas from full term small for gestational age (SGA), appropriate for gestational age (AGA) and large for gestational age (LGA) newborns, and cortisol cord blood concentration. METHODS: Twenty-five placentas from AGA, 24 SGA and 25 LGA were collected. RESULTS: SGA newborns had significantly lower and LGA newborns had significantly higher birth weight, birth length, head circumference, and placental weight than AGA counterparts. We observed a direct correlation between placental weight and birth weight, birth length and head circumference, and higher cord F levels in SGA newborns. The 11beta-HSD1 expression was similar among the SGA, AGA, and LGA placentas. However, within the placentas of SGA newborns, the 11beta-HSD1 mRNA levels were significantly reduced in the chorionic plate compared with basal plate. An inverse correlation between cord F levels and activity of 11beta-HSD1 in the chorionic plate of the SGA placentas was detected. The 11beta-HSD2 activity was seven- to eightfold higher compared with 11beta-HSD1 in the placentas, and there was a lower 11beta-HSD2 activity in females' SGA placentas compared with the male SGA placentas. CONCLUSION: We observed a lower expression and activity of 11beta-HSD1 in the chorionic plate of the SGA placentas, suggesting a possible compensatory mechanism to diminish the higher cortisol fetal concentrations observed in fetuses with intrauterine growth restriction.
Authors: Rachel J Ryu; Thomas R Easterling; Steve N Caritis; Raman Venkataramanan; Jason G Umans; Mahmoud S Ahmed; Shannon Clark; Ira Kantrowitz-Gordon; Karen Hays; Brooke Bennett; Matthew T Honaker; Kenneth E Thummel; Danny D Shen; Mary F Hebert Journal: J Clin Pharmacol Date: 2018-05-07 Impact factor: 3.126
Authors: Benjamin B Green; David A Armstrong; Corina Lesseur; Alison G Paquette; Dylan J Guerin; Lauren E Kwan; Carmen J Marsit Journal: Biol Reprod Date: 2015-03-18 Impact factor: 4.285
Authors: Heather H Burris; Joe M Braun; Hyang-Min Byun; Letizia Tarantini; Adriana Mercado; Rosalind J Wright; Lourdes Schnaas; Andrea A Baccarelli; Robert O Wright; Martha M Tellez-Rojo Journal: Epigenomics Date: 2013-06 Impact factor: 4.778
Authors: Kenneth Ayuurebobi Ae-Ngibise; Blair J Wylie; Ellen Boamah-Kaali; Darby W Jack; Felix Boakye Oppong; Steven N Chillrud; Stephaney Gyaase; Seyram Kaali; Oscar Agyei; Patrick L Kinney; Mohammed Mujtaba; Rosalind J Wright; Kwaku Poku Asante; Alison G Lee Journal: BMC Pregnancy Childbirth Date: 2019-10-29 Impact factor: 3.007
Authors: David Q Stoye; Gemma Sullivan; Paola Galdi; Clemens Kirschbaum; Gillian J Lamb; Gill S Black; Margaret J Evans; James P Boardman; Rebecca M Reynolds Journal: Psychoneuroendocrinology Date: 2021-04-10 Impact factor: 4.905
Authors: Richelle Vlenterie; Judith B Prins; Nel Roeleveld; Marleen M H J van Gelder Journal: Arch Gynecol Obstet Date: 2022-03-23 Impact factor: 2.344
Authors: Ashley S Meakin; James S M Cuffe; Jack R T Darby; Janna L Morrison; Vicki L Clifton Journal: Int J Mol Sci Date: 2021-06-15 Impact factor: 5.923